Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
Miren Ettcheto, Amanda Cano, Patrícia Regina Manzine, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 4, pp. 1814-1827
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Health Benefits and Chemical Composition of Matcha Green Tea: A Review
Joanna Kochman, Karolina Jakubczyk, Justyna Antoniewicz, et al.
Molecules (2020) Vol. 26, Iss. 1, pp. 85-85
Open Access | Times Cited: 219
Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
Teeba Athar, Khalid Al Balushi, Shah Alam Khan
Molecular Biology Reports (2021) Vol. 48, Iss. 7, pp. 5629-5645
Open Access | Times Cited: 185
Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies
Umair Shabbir, Muhammad Sajid Arshad, Aysha Sameen, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 690-690
Open Access | Times Cited: 145
Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants
Feng Jin, Youle Zheng, Mingyue Guo, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 3988-4024
Open Access | Times Cited: 67
Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease
Germán Plascencia‐Villa, George Perry
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1628-1628
Open Access | Times Cited: 58
Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
Jing Zhao, Xinyue Liu, Weiming Xia, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 129
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Kamal Niaz, et al.
Molecules (2020) Vol. 25, Iss. 6, pp. 1267-1267
Open Access | Times Cited: 112
Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A Review of Human Studies
Snježana Petrović, Aleksandra Arsić, Danijela Ristić-Medić, et al.
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1128-1128
Open Access | Times Cited: 89
Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral
Viviana Sandoval, Hèctor Sanz‐Lamora, Giselle Arias, et al.
Nutrients (2020) Vol. 12, Iss. 8, pp. 2393-2393
Open Access | Times Cited: 82
Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
Priscila Baltazar Gonçalves, Ana Carolina Rennó Sodero, Yraima Cordeiro
Biomolecules (2021) Vol. 11, Iss. 5, pp. 767-767
Open Access | Times Cited: 74
ROS-Induced mtDNA Release: The Emerging Messenger for Communication between Neurons and Innate Immune Cells during Neurodegenerative Disorder Progression
Yuanxin Zhao, Buhan Liu, Long Xu, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 1917-1917
Open Access | Times Cited: 65
Epigallocatechin-3-Gallate Provides Protection Against Alzheimer’s Disease-Induced Learning and Memory Impairments in Rats
Shanji Nan, Peng Wang, Yizhi Zhang, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 2013-2024
Open Access | Times Cited: 58
Green Tea Catechins Attenuate Neurodegenerative Diseases and Cognitive Deficits
Obaid Afzal, Mahmood Hassan Dalhat, Abdulmalik Saleh Alfawaz Altamimi, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7604-7604
Open Access | Times Cited: 47
Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Green tea catechin epigallocatechin gallate alleviates high‐fat diet‐induced obesity in mice by regulating the gut–brain axis
Jihong Zhou, Lejia Ding, Wei Chen, et al.
Food Frontiers (2023) Vol. 4, Iss. 3, pp. 1413-1425
Open Access | Times Cited: 31
Revisiting the Role of Vitamins and Minerals in Alzheimer’s Disease
Harsh Shah, Fereshteh Dehghani, Marjan Ramezan, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 415-415
Open Access | Times Cited: 27
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Adelaide Carrara, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 180-180
Open Access | Times Cited: 25
Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Rengasamy Balakrishnan, Khoshnur Jannat, Dong‐Kug Choi
Redox Biology (2024) Vol. 71, pp. 103105-103105
Open Access | Times Cited: 11
Sesamol Attenuates Amyloid Peptide Accumulation and Cognitive Deficits in APP/PS1 Mice: The Mediating Role of the Gut–Brain Axis
Qing Liu, Tianzhi Xie, Yujia Xi, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 43, pp. 12717-12729
Closed Access | Times Cited: 44
Protein Tyrosine Phosphatase 1B (PTP1B): A Comprehensive Review of Its Role in Pathogenesis of Human Diseases
Dominika Kołodziej, Łukasz Sobczak, Krzysztof Z. Łączkowski
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7033-7033
Open Access | Times Cited: 7
Effects and Mechanisms of Tea on Parkinson’s Disease, Alzheimer’s Disease and Depression
Min Luo, Ren‐You Gan, Bangyan Li, et al.
Food Reviews International (2021) Vol. 39, Iss. 1, pp. 278-306
Closed Access | Times Cited: 37
CREB nuclear transcription activity as a targeting factor in the treatment of diabetes and diabetes complications
Khaled Benchoula, Ishwar S. Parhar, Priya Madhavan, et al.
Biochemical Pharmacology (2021) Vol. 188, pp. 114531-114531
Closed Access | Times Cited: 33
Can Natural Products Exert Neuroprotection without Crossing the Blood–Brain Barrier?
Manon Leclerc, Stéphanie Dudonné, Frédéric Calon
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3356-3356
Open Access | Times Cited: 31
Insights into prevention mechanisms of bioactive components from healthy diets against Alzheimer's disease
Jingwen Wang, Zhi‐Ling Yu, Peng Ye, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 119, pp. 109397-109397
Open Access | Times Cited: 11
Effects of a High-Fat Diet on Insulin-Related miRNAs in Plasma and Brain Tissue in APPSwe/PS1dE9 and Wild-Type C57BL/6J Mice
Melina Rojas, Nil Novau-Ferré, Laia Gutiérrez-Tordera, et al.
Nutrients (2024) Vol. 16, Iss. 7, pp. 955-955
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top